Report Detail

Pharma & Healthcare Global Hereditary Angioedema Treatment Market Outlook 2021

  • RnM4253087
  • |
  • 17 November, 2020
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Hereditary Angioedema Treatment Market Overview

  • 1.1 Product Overview and Scope of Hereditary Angioedema Treatment
  • 1.2 Hereditary Angioedema Treatment Segment by Type
    • 1.2.1 Global Hereditary Angioedema Treatment Sales Growth Rate Comparison by Type (2020-2026)
    • 1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
    • 1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
    • 1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
    • 1.2.5 Others (Conventional Drugs, Pipeline Drugs)
  • 1.3 Hereditary Angioedema Treatment Segment by Application
    • 1.3.1 Hereditary Angioedema Treatment Sales Comparison by Application: (2020-2026)
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Others (online pharmacies, mail pharmacies)
  • 1.4 Global Hereditary Angioedema Treatment Market Size Estimates and Forecasts
    • 1.4.1 Global Hereditary Angioedema Treatment Revenue 2015-2026
    • 1.4.2 Global Hereditary Angioedema Treatment Sales 2015-2026
    • 1.4.3 Hereditary Angioedema Treatment Market Size by Region: 2020 Versus 2026

2 Global Hereditary Angioedema Treatment Market Competition by Manufacturers

  • 2.1 Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Hereditary Angioedema Treatment Manufacturing Sites, Area Served, Product Type
  • 2.5 Hereditary Angioedema Treatment Market Competitive Situation and Trends
    • 2.5.1 Hereditary Angioedema Treatment Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders)

3 Hereditary Angioedema Treatment Retrospective Market Scenario by Region

  • 3.1 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Hereditary Angioedema Treatment Market Facts & Figures by Country
    • 3.3.1 North America Hereditary Angioedema Treatment Sales by Country
    • 3.3.2 North America Hereditary Angioedema Treatment Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Hereditary Angioedema Treatment Market Facts & Figures by Country
    • 3.4.1 Europe Hereditary Angioedema Treatment Sales by Country
    • 3.4.2 Europe Hereditary Angioedema Treatment Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Hereditary Angioedema Treatment Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
    • 3.5.2 Asia Pacific Hereditary Angioedema Treatment Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Hereditary Angioedema Treatment Market Facts & Figures by Country
    • 3.6.1 Latin America Hereditary Angioedema Treatment Sales by Country
    • 3.6.2 Latin America Hereditary Angioedema Treatment Sales by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Country
    • 3.7.2 Middle East and Africa Hereditary Angioedema Treatment Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Hereditary Angioedema Treatment Historic Market Analysis by Type

  • 4.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
  • 4.2 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020)
  • 4.3 Global Hereditary Angioedema Treatment Price Market Share by Type (2015-2020)
  • 4.4 Global Hereditary Angioedema Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Hereditary Angioedema Treatment Historic Market Analysis by Application

  • 5.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
  • 5.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020)
  • 5.3 Global Hereditary Angioedema Treatment Price by Application (2015-2020)

6 Company Profiles and Key Figures in Hereditary Angioedema Treatment Business

  • 6.1 CSL
    • 6.1.1 Corporation Information
    • 6.1.2 CSL Description, Business Overview
    • 6.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 CSL Products Offered
    • 6.1.5 CSL Recent Development
  • 6.2 Pharming Group
    • 6.2.1 Pharming Group Corporation Information
    • 6.2.2 Pharming Group Description, Business Overview
    • 6.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 Pharming Group Products Offered
    • 6.2.5 Pharming Group Recent Development
  • 6.3 Shire plc (Takeda Pharmaceutical Company Limited)
    • 6.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
    • 6.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description, Business Overview
    • 6.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Products Offered
    • 6.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
  • 6.4 Ionis Pharmaceuticals
    • 6.4.1 Ionis Pharmaceuticals Corporation Information
    • 6.4.2 Ionis Pharmaceuticals Description, Business Overview
    • 6.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Ionis Pharmaceuticals Products Offered
    • 6.4.5 Ionis Pharmaceuticals Recent Development
  • 6.5 Attune Pharmaceuticals
    • 6.5.1 Attune Pharmaceuticals Corporation Information
    • 6.5.2 Attune Pharmaceuticals Description, Business Overview
    • 6.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Attune Pharmaceuticals Products Offered
    • 6.5.5 Attune Pharmaceuticals Recent Development
  • 6.6 BioCryst Pharmaceuticals
    • 6.6.1 BioCryst Pharmaceuticals Corporation Information
    • 6.6.2 BioCryst Pharmaceuticals Description, Business Overview
    • 6.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 BioCryst Pharmaceuticals Products Offered
    • 6.6.5 BioCryst Pharmaceuticals Recent Development
  • 6.7 KalVista Pharmaceuticals
    • 6.6.1 KalVista Pharmaceuticals Corporation Information
    • 6.6.2 KalVista Pharmaceuticals Description, Business Overview
    • 6.6.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 KalVista Pharmaceuticals Products Offered
    • 6.7.5 KalVista Pharmaceuticals Recent Development

7 Hereditary Angioedema Treatment Manufacturing Cost Analysis

  • 7.1 Hereditary Angioedema Treatment Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
  • 7.4 Hereditary Angioedema Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Hereditary Angioedema Treatment Distributors List
  • 8.3 Hereditary Angioedema Treatment Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Hereditary Angioedema Treatment Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Hereditary Angioedema Treatment by Type (2021-2026)
  • 10.2 Hereditary Angioedema Treatment Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Hereditary Angioedema Treatment by Application (2021-2026)
  • 10.3 Hereditary Angioedema Treatment Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Hereditary Angioedema Treatment by Region (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Hereditary Angioedema Treatment market is segmented into
    C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
    Selective Bradykinin B2 Receptor Antagonists (Firazyr)
    Kallikrein Inhibitors (Kalbitor, Takhzyro)
    Others (Conventional Drugs, Pipeline Drugs)

    Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Others (online pharmacies, mail pharmacies)

    Global Hereditary Angioedema Treatment Market: Regional Analysis
    The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Hereditary Angioedema Treatment market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Hereditary Angioedema Treatment Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Hereditary Angioedema Treatment market include:
    CSL
    Pharming Group
    Shire plc (Takeda Pharmaceutical Company Limited)
    Ionis Pharmaceuticals
    Attune Pharmaceuticals
    BioCryst Pharmaceuticals
    KalVista Pharmaceuticals


    Summary:
    Get latest Market Research Reports on Hereditary Angioedema Treatment. Industry analysis & Market Report on Hereditary Angioedema Treatment is a syndicated market report, published as Global Hereditary Angioedema Treatment Market Outlook 2021. It is complete Research Study and Industry Analysis of Hereditary Angioedema Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,171.47
    3,257.21
    4,342.94
    2,401.55
    3,602.33
    4,803.11
    303,148.60
    454,722.90
    606,297.20
    213,826.57
    320,739.86
    427,653.14
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report